Webster Equity Partners has entered into a definitive agreement to acquire Lifecore Biomedical in a transaction valued at up to $663.7 million, according to a news release. Lifecore (Nasdaq: LFCR), founded in 1965 and based in Chaska, Minnesota, is a contract development and manufacturing organization specializing in the development and fill/finish of sterile injectable pharmaceuticals. […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.